Manufacturing / Biological Products, Except Diagnostic Substances
NEUROCRINE BIOSCIENCES INC
NBIX
$146.54
-$5.60 (-3.69%)
Price as of Sep 18, 2026 22:35 UTC
16 B
Market Cap (Large Cap)
Oct 26
Next Earnings
Technical Signals
as of Sep 16
Bearish
0 of 7
Trend
- Above 20-day average $155.69
- Above 50-day average $158.83
- Above 200-day average $151.22 · -1.1%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) —
- Momentum cross (20/50) Down · 21d ago
Volume
- Below-average volume 1.0x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Heat Map
Delta-risk grid for NBIX options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
40 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Aug 04, 2026 | Onyia Jude | Gift | 2,409 | $0 | -11.9% | |
| Jul 29, 2026 | Norwalk Leslie V | Exercise | 842 | $117,400 | +4.9% | |
| Jul 29, 2026 | Norwalk Leslie V | Exercise | 842 | $0 | -19.1% | |
| Jul 28, 2026 | Norwalk Leslie V | Sell | 1,250 | $227,508 | -19.7% | |
| Jul 10, 2026 | Delaet Ingrid | Sell | 4,367 | $790,514 | -19.2% | |
| Jul 10, 2026 | Delaet Ingrid | Exercise | 4,367 | $0 | -17.4% | |
| Jul 10, 2026 | Delaet Ingrid | Exercise | 4,367 | $462,989 | +37.9% | |
| Jul 09, 2026 | Lippoldt Darin | Exercise | 10,000 | $814,900 | +79.4% | |
| Jul 09, 2026 | Lippoldt Darin | Sell | 10,000 | $1,796,014 | -18.6% | |
| Jul 09, 2026 | Delaet Ingrid | Exercise | 8,433 | $0 | -19.0% |
Politician Trades in NBIX
| Date | Politician | Party | Type | Amount | Since Buy |
|---|---|---|---|---|---|
| Jun 17, 2025 | Lisa C. McClain | R | Sale | $1K-$15K | — |
| Jun 17, 2025 | Lisa C. McClain | R | Sale | $1K-$15K | — |
| Jun 11, 2025 | Lisa C. McClain | R | Purchase | $1K-$15K | +17.8% |
| Nov 19, 2024 | Michael T. McCaul | R | Sale | $15K-$50K | — |
| Nov 19, 2024 | Michael T. McCaul | R | Sale | $15K-$50K | — |
| Aug 26, 2024 | Michael T. McCaul | R | Sale | $1K-$15K | — |
| Aug 26, 2024 | Michael T. McCaul | R | Sale | $1K-$15K | — |
| Oct 27, 2023 | Michael T. McCaul | R | Sale | $50K-$100K | — |
| Oct 27, 2023 | Michael T. McCaul | R | Sale | $15K-$50K | — |
| Aug 14, 2023 | Michael T. McCaul | R | Purchase | $50K-$100K | +38.5% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 04, 2026 | Q2 2026 | $1.59 | |||
| Jul 30, 2026 | Q2 2026 | $1.36 | |||
| Jul 28, 2026 | Q2 2026 | $1.61 | |||
| Jun 30, 2026 | Q2 2026 | $1.04 | $2.85 | +175.3% | Beat |
| Mar 31, 2026 | Q1 2026 | $1.37 | $1.39 | +1.5% | Beat |
| Dec 31, 2025 | Q4 2025 | $1.20 | $1.91 | +59.5% | Beat |
| Sep 30, 2025 | Q3 2025 | $1.62 | $2.04 | +26.1% | Beat |
| Jun 30, 2025 | Q2 2025 | $0.99 | $1.06 | +7.0% | Beat |
Track NBIX with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for NBIX and your entire portfolio.